What Matters Most for NIH SBIR/STTR Applicants
- TABA has fundamentally changed.
NOT-OD-26-073 and NOT-OD-26-076 work together.
Applicants can no longer rely on post-award TABA supplements.
Commercialization assistance must be planned and budgeted upfront. - Foreign disclosure requirements have expanded.
NOT-OD-26-075 aligns NIH with broader federal efforts to strengthen research security and supply-chain transparency. - NHLBI budget restrictions were removed.
NOT-HL-26-005 simplifies budgeting for NHLBI applicants by eliminating institute-specific guidance that had created confusion. - Commercialization training remains available.
NIH continues to support I-Corps participation as a pathway to strengthen customer discovery and commercialization readiness.
| Notice | Title | Agency / Office | Date | Basic Information |
|---|---|---|---|---|
| NOT-OD-26-076 | Notice to Rescind NOT-OD-24-077 | NIH / OD | April 20 | Rescinds prior guidance allowing TABA funding through an administrative supplement. |
| NOT-OD-26-073 | Policy Changes to SBIR and STTR Discretionary Technical and Business Assistance | NIH / OD | April 20 | Updates NIH policy for requesting Technical and Business Assistance (TABA) in SBIR/STTR applications. |
| NOT-OD-26-075 | Policy Changes to SBIR and STTR Foreign Disclosure and Risk Management | NIH / OD | April 20 | Outlines foreign disclosure and risk management policy changes for SBIR/STTR applicants. |
| NOT-HL-26-005 | Notice to Rescind NOT-HL-24-008 | NHLBI | May 13 | Rescinds prior NHLBI-specific budget guidance for SBIR/STTR applications. |
| NOT-OD-26-037 | I-Corps at NIH Entrepreneurship Program | NIH / OD | March 5 | Provides commercialization training for Phase I SBIR/STTR awardees. |